Based on the observations in the above-mentioned studies, somatostatin receptors or relevant mRNA transcripts were noted to be prevalent in extragastric lymphomas, Hodgkin lymphoma, non-Hodgkin lymphoma, DLBCL, gastric cancer (SSTR2), thymoma (SSTR3), Merkel cell carcinoma (SSTR2), some subsets of lung cancer (SSTR2), meningioma (SSTR2), pheochromocytoma/paraganglioma (SSTR2, SSTR3), head and neck cancer (SSTR1, 2, 5) and certain gynecologic cancers (SSTR1). Here, SSTR3 is linked to paraganglioma.